Navigation Links
DNAscope AT from Biomedical Photometrics Inc.

ProductsDNAscope AT from Biomedical Photometrics Inc.
Company Biomedical Photometrics Inc.
Item DNAscope AT
Price 
Description 'A New Concept in Microarrays: Biomedical Photometrics Inc. (Waterloo, Ontario, Canada) and CLONDIAG chip technologies GmbH (Jena, Germany) have collaborated to develop a fluorescence reader for the new CLONDIAG ArrayTube System. The DNAscope AT is based on BPIs patented MACROscope technology. The new DNAscope AT automatically reads up to six ArrayTubes in sequence using a confocal laser scanning mechanism like that used in BPIs other DNAscope readers for Genetic Microarrays. Reading time is less than one minute per fluorophore per ArrayTube. The initial system contains two lasers and is housed in a small case that fits easily on the laboratory bench.

Main Features:

  • Includes control module (computer), monitor, and software.
  • Easy-to-use
  • reads up to 6 ArrayTubes in one removable cartridge
  • Fast scanning: scan 1 ArrayTube in 1 minute (per fluorophore)
  • Confocal design greatly reduces background signal and improves signal-to-noise.
  • Stable slide holder: No vibration enables imaging wet samples. No worries about losing focus or registration.
  • Upgradeable to include a third laser light source. Up to 8 different emission filters can be provided.
  • 16 bit dynamic range, optimize useful dynamic range with calibration feature and gain control.
Applications: Genotyping, SNP analysis, Diagnostics, Pathogen Detection.
Info Biomedical Photometrics Inc.Biomedical Photometrics Inc.
550 Parkside Drive, Unit A12
Waterloo, Ontario, Canada
N2L 5V4
Customer Service: (519) 886-9013
Fax Number: (519) 886-5300
Web Site: http://www.genefocus.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Open Frame DNAscope from Biomedical Photometrics Inc.
2. The DNAscope LM from Biomedical Photometrics Inc.
3. The DNAscope IV & V from Biomedical Photometrics Inc.
4. BioProfile Chemistry Analyzer from Nova Biomedical
5. Normal Human Serum from 3H Biomedical AB
6. Monocyte Activation Kit from 3H Biomedical AB
7. Macrophage Differentiation Kit from 3H Biomedical AB
8. MoDC Differentiation Kit from 3H Biomedical AB
9. Stem Cell Expansion Media 1 from 3H Biomedical AB
10. Human AB Serum from 3H Biomedical AB
11. UCB Neutrophil Chip-IHC from 3H Biomedical AB
di-3-ANEPPDHQ from Molecular Probes (Invitrogen)
REact 2 Buffer from Invitrogen
Phosphate Colorimetric Assay Kit from R&D Systems
Feline IL-10 ELISpot Development Kit from R&D Systems
Biology Products:
(Date:12/2/2009)... secondhand smoke for a prolonged period of time a...t cancer, even in women who never smoked cigarette...re to side-stream smoke could increase risk of bre...Reynolds, Ph.D., senior research scientist at the ...e. "While no single epidemiologic study can answer...
(Date:12/2/2009)...A Smoky Mountain forest,s woodland herb population...est understories recover from logging, according t...gging in portions of the forest nearly 80 years ag...ndary forest floor was similar to that of undistur...fessor of forestry and natural resources, said tha...
(Date:12/2/2009)...sity of Georgia College of Veterinary Medicine hav...pen new avenues for treating Ichthyophthirius mult...tozoan parasite that commonly attacks freshwater f...researchers found that Ich harbors two apparently ...ich are usually found free-living, and Rickettsia,...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 1STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 3Wonderbox Technologies 28R 29 Announces 2nd Annual Super User of the Year 51803 1Wonderbox Technologies 28R 29 Announces 2nd Annual Super User of the Year 51803 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 1NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 3
...or phosphorus releases into the Everglades seem su...nts and animals from damage, but pollutant levels ... of the Everglades outer edges. , A six-year stud...rious phosphorus levels affected natural communiti... In an Oct. 24, 2007 report in the online edition ...
...g centuries may trigger a new mass extinction even...ies would be wiped out, warn scientists at the Uni... has, for the first time, discovered a close assoc...study that has examined the relationship over the ...ecord available. , Matching data sets of marine ...
...hat viruses may contribute to cancer by causing ex...growth of surviving cells with cancerous traits. V...iping out normal cells that support the replicatio...ave acquired defects in their circuitry. When this...elop say study authors, led by Preet M. Chaudhary,...
Other Biology News:Everglades phosphorus limits on the right track, but more is needed 2Everglades phosphorus limits on the right track, but more is needed 3Fossil record supports evidence of impending mass extinction 2Study proposes new theory of how viruses may contribute to cancer 2
(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNewsw...her the leaders in technology development and prod...d MEMS, announced the December 11th deadline for t..., Now in its 14th year, TechConnect World, in as...titute (NSTI), and the Clean Technology and Sustai...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...on its novel oral JAK2 inhibitor, SB1518, at The A...and Exposition in New Orleans. ,, Data will be ... dose-escalation trial of SB1518 detailing its saf...mic (PK/PD) profile in dose levels ranging from 10...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswi..." or the "Company") (NYSE: SCR ), a leading phar..., manufacturing, and marketing of branded,generic ...nounced that 105 of,its drugs have been included i...), which was issued by China,s Ministry of Human R...
(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-Asi...es; markets are in turmoil and uncertainty is part...hat the pharma industry has been,relatively immune... take a,vacation. , During the midst of t...iant Johnson & Johnson inaugurated an R&D ...
Breaking Biology Technology:Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3